Ondas Holdings (ONDS) shares fell roughly 25% over the trailing 30 days, sliding from a closing price of about $9.74 on August 11 to $7.29 on September 9, 2026. The decline unfolded despite record second-quarter revenue of $83.8 million (up more than 13x year over year) and an increase in full-year guidance to $525–$550 million.

Carpenter Technology (CRS) shares fell about 18.1% over the trailing 30 days, from roughly $559.75 on August 10 to $458.45 at the September 9 close, despite record fiscal fourth-quarter results. The decline followed the company's fiscal Q4 2026 report, which beat on earnings per share ($3.23 versus the $3.08 consensus) but posted revenue of $851.0 million, slightly below the $863.3 million estimate.

Credo Technology (CRDO) declined roughly 32% over the 30 days ending in early September 2026, despite delivering record quarterly results. The selloff followed a "beat-and-raise" fiscal Q1 2027 report, as investors focused on narrowing margins and heavy customer concentration rather than surging revenue.

TJX shares fell roughly 19% over the trailing 30 days, from about $155.74 to $126.12, extending a decline from the stock's June peak near $170. The selloff was triggered by the fiscal 2027 second-quarter earnings report released August 19, when near-term third-quarter guidance landed below analyst expectations.

RKLB fell roughly 21% over the last 30 days, from about $80 to the low-$60s, extending a multi-month pullback from its 52-week high. The decline came even as the company reported record second-quarter revenue of $234.1 million, up 62% year over year, and a record $2.36 billion backlog.

The central question is whether Summit Therapeutics (SMMT) can reclaim the $30 level, roughly 71% above its recent price near $17.54. The strongest bullish case rests on ivonescimab, a Phase III oncology drug candidate with a pivotal lung cancer readout expected in the second half of 2026.

Chime Financial (CHYM) trades near $34.55, up roughly 9% over the trailing 30 days, extending a ~44% August surge that followed its second-quarter earnings report. Q2 2026 revenue rose 27% year over year to $670 million, while EPS of $0.07 beat the consensus estimate of -$0.01.

Hecla Mining (NYSE: HL ) traded near $20.85 recently, leaving a roughly 44% climb required to reach the widely discussed $30 price target. The stock's 52-week high of $34.17, set in January 2026, shows $30 is an achievable level the shares have already visited during a strong silver rally.

KORU advanced roughly +72% over the trailing 30 days, rebounding sharply from a mid-summer trough as South Korean equities recovered. The fund remains down approximately -62% over the trailing three months, reflecting the extreme two-way volatility of daily 3x leverage.

The Tradr 2X Long BE Daily ETF gained roughly 51% over the trailing 30 days, rebounding from a July trough near $15 to about $22.62. The move mirrors a strong recovery in its sole underlying exposure, Bloom Energy Corp. (BE) , which advanced about 29% over the same stretch.

MSTY gained roughly 15% over the trailing 30 days, climbing from about $12.51 to $14.40 as its underlying, MSTR , rebounded sharply. The fund remains down roughly 26% over the trailing three months, reflecting a steep June drawdown in MSTR that the synthetic covered-call strategy largely mirrored on the downside.

HOOW advanced roughly 14% over the trailing 30 days, rebounding from a late-July trough to finish near $28.90. The fund is an actively managed, non-diversified ETF (exchange-traded fund) that targets approximately 1.2x (120%) the weekly total return of Robinhood Markets ( HOOD ) while paying weekly distributions.

RAM is a leveraged ETF (exchange-traded fund) that seeks 200% of the daily return of the Roundhill Memory ETF (DRAM), a concentrated basket of global memory-chip makers. The fund launched in June 2026 and is engineered for short-term traders, with daily reset mechanics that can compound losses over multi-day holding periods.

AMD shares recently traded near $474, roughly 4% higher than their level 30 days earlier, as strong AI data center results offset post-earnings profit taking. Second-quarter revenue rose 50% year over year to $11.54 billion, while data center revenue more than doubled to $6.7 billion, now 58% of total sales.

The selected price target is $3.00 , roughly 20% above recent trading levels near $2.50 and the highest current analyst price target on the Street. The strongest bullish case rests on improving quarterly results, a dual revenue model tied to renewable natural gas (RNG) and environmental credits, and progress on agricultural-waste projects.

Torrid Holdings Inc. ( CURV ) trades near $2.50, with a 52-week high of $2.86, making the $3 level a meaningful psychological and technical milestone roughly 20% above recent prices. The strongest bullish case rests on a turnaround that is finally showing traction, including positive comparable-store sales in July and August and improving profitability guidance.

Nokia's American Depositary Receipt (ADR) was recently trading near $10.65 , making a $20 target a gain of roughly 88% from current levels. The stock has already shown it can trade far higher — it touched a 52-week high of $17.45 in early June 2026 before pulling back sharply.

The focal price target is $250 , roughly 28% above recent trading near $195 and closely aligned with the analyst consensus near $248. The strongest bullish case rests on SK hynix's leadership in high-bandwidth memory (HBM), tight memory supply, multi-year customer contracts, and a massive 40 trillion won share buyback.

SIG is up +18.53% to $97.99 during Wednesday's regular session, up from a prior close of $82.67. The rally follows a fiscal Q2 earnings beat: adjusted EPS of $2.19 versus a ~$1.74 consensus, with same-store sales up +2.2%.

The price target in focus is $25 per share , roughly 14% above EOS's recent trading range near $22. The strongest bullish case is valuation, not momentum: EOS trades at an unusually wide discount to its net asset value (NAV), with the NAV itself already sitting around $24.40.